WO2002009747A1 - Procede de prophylaxie et de traitement des maladies du systeme immunitaire et moyen correspondant - Google Patents
Procede de prophylaxie et de traitement des maladies du systeme immunitaire et moyen correspondant Download PDFInfo
- Publication number
- WO2002009747A1 WO2002009747A1 PCT/RU2001/000250 RU0100250W WO0209747A1 WO 2002009747 A1 WO2002009747 A1 WO 2002009747A1 RU 0100250 W RU0100250 W RU 0100250W WO 0209747 A1 WO0209747 A1 WO 0209747A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- diseases
- immune system
- larvae
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Definitions
- vaccination is carried out by the larvae of such a specially bred line of German measles.
- One dose of the vaccine contains 3000 to 6000 larvae.
- the vaccination may be produced as a one-off, two-and-a-half - with an interval of 2 ... 3 days [Br. ⁇ . ⁇ . Erichinella as an immune stimulus / Abstracts of the 9th Int. ⁇ iller ⁇ . ⁇ ⁇ ihinellosis. Hexico, Hexico, August 19-22, 1996. - P.269].
- the purpose of the invention is to increase the efficacy and treatment of diseases of the human immune system and the incidence of the disease, and the The stated goal is achieved by the following.
- the method of treatment and treatment of diseases of the immune system is mediated by the drug, the main ingredient of which is 2 from 1000 to 6000 live larvae of the family ⁇ , 1895 (one dose), possessing low pathogenic and high immunogenic properties.
- the drug the main ingredient of which is 2 from 1000 to 6000 live larvae of the family ⁇ , 1895 (one dose), possessing low pathogenic and high immunogenic properties.
- the usual therapeutic component is produced, as is the case with pulmonary disease.
- Dosage of a preparation for a new product may contain a larger number of individuals, t. ⁇ .
- the organism already possesses the immune system after the treatment of pulmonary disease.
- the number of individuals present in the dose is controlled depending on the type of disease, age, gender, the degree of the severity of the patient, the presence of other illnesses or treatment.
- the action of the preparation is based on the following.
- P ⁇ sle ⁇ aln ⁇ g ⁇ ⁇ iema ⁇ e- ⁇ a ⁇ a ⁇ a lichin ⁇ i vned ⁇ yayu ⁇ sya in slizis ⁇ uyu ⁇ b ⁇ l ⁇ ch ⁇ u ⁇ n ⁇ g ⁇ ⁇ dela ⁇ ishechni ⁇ a where ⁇ ev ⁇ aschayu ⁇ sya in imag ⁇ , ⁇ ichem sam ⁇ i ⁇ zhdayu ⁇ lichin ⁇ , ⁇ ye with ⁇ m ⁇ vi ⁇ azn ⁇ sya ⁇ sya ⁇ ⁇ ganizmu and ⁇ selyayu ⁇ sya in s ⁇ ele ⁇ ny ⁇ myshtsa ⁇ .
- Imagoes and larvae are allotted during their development a complex complex of antigens.
- the pact cells are disrupted, and the affected parts of the ores are replaced by the regenerative cages of these organs or the connecting tissue. Acquired immunity after double immunization is lost in a person up to 8 years old.
- the preparation is prepared from the larvae of a special vigorous line of blood cells found in the skeletal muscle of the animal. ⁇ . ⁇ .
- Diagnosis Basal skin of the nose of the nose. ⁇ 1993, the removal of the last laser was made, after which the relapse began. The amount of growth was gradually increasing in size, while the size of the nose was also reduced. ⁇ 1996, radiation therapy was introduced in the city of Babarsky SED 60 ⁇ (epithelization of a radiation ulcer). The year the ulcer was forgotten, then it began to swell, to disappear. After a light blow to a veterinary accident, it appeared that the russia was growing, it began to recover, increasing in size.
- the first dose of the drug was inoculated in April 1998.
- the dose was -2500 larvae of the solution in 2 mg of a physiological solution.
- the additional purpose of the product is “Children” (the company “Kizon”) and the outside is an ointment with prypolis. ⁇ gaze ⁇ rion
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA200200927A EA004603B1 (ru) | 2000-07-27 | 2001-06-25 | Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления |
MXPA03000784A MXPA03000784A (es) | 2000-07-27 | 2001-06-25 | Metodo para prevenir y curar enfermedades de un sistema inmune. |
AU2001280319A AU2001280319A1 (en) | 2000-07-27 | 2001-06-25 | Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
CA002406311A CA2406311A1 (en) | 2000-07-27 | 2001-06-25 | Method for preventing and curing diseases of an immune system and a remedy for carrying out said method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000120081 | 2000-07-27 | ||
RU2000120081/14A RU2172182C1 (ru) | 2000-07-27 | 2000-07-27 | Способ профилактики и лечения заболеваний иммунной системы и средство для его осуществления |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002009747A1 true WO2002009747A1 (fr) | 2002-02-07 |
Family
ID=20238494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2001/000250 WO2002009747A1 (fr) | 2000-07-27 | 2001-06-25 | Procede de prophylaxie et de traitement des maladies du systeme immunitaire et moyen correspondant |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030077257A1 (ru) |
CN (1) | CN1457259A (ru) |
AU (1) | AU2001280319A1 (ru) |
CA (1) | CA2406311A1 (ru) |
EA (1) | EA004603B1 (ru) |
MX (1) | MXPA03000784A (ru) |
RU (1) | RU2172182C1 (ru) |
WO (1) | WO2002009747A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8404714B2 (en) * | 2008-01-04 | 2013-03-26 | Novus International, Inc. | Combinations to improve animal health and performance |
RU2506088C2 (ru) * | 2012-02-21 | 2014-02-10 | Василий Александрович Бритов | СПОСОБ ПОЛУЧЕНИЯ ВАКЦИНЫ НА ОСНОВЕ ЖИВЫХ ЛИЧИНОК НЕМАТОД РОДА Trichinella Railliet (1895) ДЛЯ ИММУНИЗАЦИИ ЖИВОТНЫХ И ЧЕЛОВЕКА, ПРИМЕНЕНИЕ МОЛОКА ЖИВОТНОГО, ИММУНИЗИРОВАННОГО ЭТОЙ ВАКЦИНОЙ, В КАЧЕСТВЕ СРЕДСТВА ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ИММУННОЙ СИСТЕМЫ, СПОСОБ ПОЛУЧЕНИЯ СЫВОРОТКИ ИЗ КРОВИ ИММУНИЗИРОВАННЫХ ЖИВОТНЫХ И СПОСОБ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ИММУННОЙ СИСТЕМЫ С ПОМОЩЬЮ ТАКОЙ СЫВОРОТКИ |
RU2489026C1 (ru) * | 2012-03-05 | 2013-08-10 | Государственное научное учреждение (ГНУ) Всероссийский научно-исследовательский институт гельминтологии им. К.И. Скрябина (ВИГИС) | Способ обезвреживания личинок трихинелл методом замораживания в тушках некоторых пушных зверей |
GB201402909D0 (en) * | 2014-02-19 | 2014-04-02 | Univ Southampton | Treating infection |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0438803A2 (en) * | 1990-01-26 | 1991-07-31 | Immunomedics, Inc. | Vaccines against cancer and infectious diseases |
US5273745A (en) * | 1988-03-01 | 1993-12-28 | Volker R. Schirrmacher | Virus-modified tumor vaccines for immunotherapy of tumor metastases |
WO1995009650A1 (en) * | 1993-10-01 | 1995-04-13 | Luanfarma S.R.L. | Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
EP0540128B1 (en) * | 1988-09-26 | 1996-08-07 | Biotechnology Australia Pty. Ltd. | Nematode vaccine |
-
2000
- 2000-07-27 RU RU2000120081/14A patent/RU2172182C1/ru not_active IP Right Cessation
-
2001
- 2001-06-25 CA CA002406311A patent/CA2406311A1/en not_active Abandoned
- 2001-06-25 US US10/204,483 patent/US20030077257A1/en not_active Abandoned
- 2001-06-25 AU AU2001280319A patent/AU2001280319A1/en not_active Abandoned
- 2001-06-25 EA EA200200927A patent/EA004603B1/ru not_active IP Right Cessation
- 2001-06-25 MX MXPA03000784A patent/MXPA03000784A/es unknown
- 2001-06-25 CN CN01813380A patent/CN1457259A/zh active Pending
- 2001-06-25 WO PCT/RU2001/000250 patent/WO2002009747A1/ru active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5273745A (en) * | 1988-03-01 | 1993-12-28 | Volker R. Schirrmacher | Virus-modified tumor vaccines for immunotherapy of tumor metastases |
EP0540128B1 (en) * | 1988-09-26 | 1996-08-07 | Biotechnology Australia Pty. Ltd. | Nematode vaccine |
EP0438803A2 (en) * | 1990-01-26 | 1991-07-31 | Immunomedics, Inc. | Vaccines against cancer and infectious diseases |
WO1995009650A1 (en) * | 1993-10-01 | 1995-04-13 | Luanfarma S.R.L. | Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof |
Non-Patent Citations (1)
Title |
---|
V.I. APANASEVICH ET AL.: "Protivoopukholevy effeckt trikhinelleza v experimentalnom kantseroneze", 1998, AKTUALNYE PROBLEMY V ONKOLOGII. 3-Y DALNEVOSTOCHNY MEZHDURARODNY SIMPOZIUM, VLADIVOSTOK, DALNAUKA * |
Also Published As
Publication number | Publication date |
---|---|
CA2406311A1 (en) | 2002-10-10 |
MXPA03000784A (es) | 2004-11-01 |
AU2001280319A1 (en) | 2002-02-13 |
CN1457259A (zh) | 2003-11-19 |
RU2172182C1 (ru) | 2001-08-20 |
US20030077257A1 (en) | 2003-04-24 |
EA004603B1 (ru) | 2004-06-24 |
EA200200927A1 (ru) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Richardson | Diseases of domestic guinea pigs | |
Dox et al. | Melloni's illustrated medical dictionary | |
CA2497644C (en) | Whole bacterial cells as immune modulator | |
WO2002009747A1 (fr) | Procede de prophylaxie et de traitement des maladies du systeme immunitaire et moyen correspondant | |
KR20020069239A (ko) | 점막면역 조절제 및 그 용도 | |
Simon et al. | Hypersensitiveness to pituitary extracts | |
EP2694541A1 (de) | Antikörperprodukt, umfassend n spezifische antikörper | |
US10959450B2 (en) | Food composition for relieving symptoms of allergic and autoimmune diseases | |
WO2009115429A1 (en) | Food preparation and pharmaceutical composition containing an embryonic extract | |
US9999667B2 (en) | Vaccination response for immunodeficiency disorders or high cortisol | |
RU2709144C1 (ru) | Способ лечения диспепсии телят | |
CN103432425B (zh) | 一种用于治疗动物破伤风的药物制剂 | |
RU2528916C1 (ru) | Способ комплексного лечения коров при послеродовом эндометрите | |
JP2019513797A (ja) | シャーガスに関する抗原および抗体および組成物、それらの方法および使用 | |
Grunau et al. | An interesting presentation of pediatric tetanus | |
RU2259843C1 (ru) | Способ лечения миксоматоза кроликов | |
RU2517119C1 (ru) | Способ профилактики инфекционного конъюнктиво-кератита крупного рогатого скота | |
RU2506088C2 (ru) | СПОСОБ ПОЛУЧЕНИЯ ВАКЦИНЫ НА ОСНОВЕ ЖИВЫХ ЛИЧИНОК НЕМАТОД РОДА Trichinella Railliet (1895) ДЛЯ ИММУНИЗАЦИИ ЖИВОТНЫХ И ЧЕЛОВЕКА, ПРИМЕНЕНИЕ МОЛОКА ЖИВОТНОГО, ИММУНИЗИРОВАННОГО ЭТОЙ ВАКЦИНОЙ, В КАЧЕСТВЕ СРЕДСТВА ДЛЯ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ИММУННОЙ СИСТЕМЫ, СПОСОБ ПОЛУЧЕНИЯ СЫВОРОТКИ ИЗ КРОВИ ИММУНИЗИРОВАННЫХ ЖИВОТНЫХ И СПОСОБ ПРОФИЛАКТИКИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ИММУННОЙ СИСТЕМЫ С ПОМОЩЬЮ ТАКОЙ СЫВОРОТКИ | |
ZA200300661B (en) | Method for preventing and curing diseases of an immune system and a remedy for carrying out said method. | |
RU2620548C1 (ru) | Способ профилактики респираторных болезней телят | |
Lockhart | Ants and other greatmedicines | |
Stoskopf et al. | Immobilization of two captive adult Nile hippo (Hippopotamus amphibius) | |
Roslyak | Practical experience in the treatment and prevention of viral diseases, including coronavirus in 2020-2023 | |
KvS et al. | Clinical rabies: is cure possible? | |
RU2213573C2 (ru) | Способ профилактики паратифа телят |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10204483 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200200927 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2406311 Country of ref document: CA |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/00661 Country of ref document: ZA Ref document number: PA/a/2003/000784 Country of ref document: MX Ref document number: 200300661 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018133800 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 250/MUMNP/2003 Country of ref document: IN |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |